Session Information

WCLC 2017

18th World Conference on Lung Cancer

Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan

Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.
Presentation Date(s):
- Oct 15 - 18, 2017
- Total Presentations: 2295
Register to Attend WCLC Return to WCLC 2017 Website Switch to Virtual Meeting
Enter Virtual Meeting Access Code

All Days Saturday
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18

Filter Results:

Show Only CME Accredited Sessions

20153

+
P1.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
- 22619
  
  +
  
  P1.04-010 - CheckMate 870: An Open-label Safety Study of Nivolumab in Previously Treated Patients With Non-Small Cell Lung Cancer in Asia
  
  09:30 - 09:30 | Presenter: Shun Lu | Author(s): Li Zhang, Ying Cheng, Jie Wang, C. Wang, M. Wang, X. Li, Q. Wu, Yi-Long Wu
  Abstract
  
  Loading...
20156

+
P1.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
- 22706
  
  +
  
  P1.07-038 - The Potential Clinical Application of Comprehensive Genomic Profiling in Targeted Therapy and Immunotherapy of Lung Cancer
  
  09:30 - 09:30 | Presenter: Mingwu Chen | Author(s): J. Hu, L. Wang, G. Li, C. Liu, M. Wang, L. Dai, W. Wang, G. Chirn, S. Mu, L. Chen, J. Hu, M. Yao, K. Wang
  Abstract
  
  Loading...
20167

+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
- 23312
  
  +
  
  P2.03-041 - The Concentration of Avitinib in Cerebrospinal Fluid and Its Efficacy and Safety in NSCLC Patients with T790M Mutation
  
  09:30 - 09:30 | Presenter: Hanping Wang | Author(s): L. Zhang, X. Zheng, X. Si, Xiaoxia Cui, M. Wang
  Abstract
  
  Loading...
- 23321
  
  +
  
  P2.03-050 - The Efficacy of EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer Harboring G719X Mutation
  
  09:30 - 09:30 | Presenter: Hanping Wang | Author(s): L. Zhang, T. Lu, X. Zhang, Xiaoyan Si, M. Wang
  Abstract
  
  Loading...
20174

+
P2.10 - Nursing/Palliative Care/Ethics
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Nursing/Palliative Care/Ethics
- 23456
  
  +
  
  P2.10-002 - A Study on the Relation between Gender and Quality of Life for Lung Cancer Patients
  
  09:30 - 09:30 | Presenter: Yi-Lin Wu | Author(s): N. Ko, W.M. Wang, H.P. Wang
  Abstract
  
  Loading...

Session Information

WCLC 2017

18th World Conference on Lung Cancer

Enter Virtual Meeting Access Code

+

P1.04 - Clinical Design, Statistics and Clinical Trials

+

P1.04-010 - CheckMate 870: An Open-label Safety Study of Nivolumab in Previously Treated Patients With Non-Small Cell Lung Cancer in Asia

+

P1.07 - Immunology and Immunotherapy

+

P1.07-038 - The Potential Clinical Application of Comprehensive Genomic Profiling in Targeted Therapy and Immunotherapy of Lung Cancer

+

P2.03 - Chemotherapy/Targeted Therapy

+

P2.03-041 - The Concentration of Avitinib in Cerebrospinal Fluid and Its Efficacy and Safety in NSCLC Patients with T790M Mutation

+

P2.03-050 - The Efficacy of EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer Harboring G719X Mutation

+

P2.10 - Nursing/Palliative Care/Ethics

+

P2.10-002 - A Study on the Relation between Gender and Quality of Life for Lung Cancer Patients

Stay Connected